Literature DB >> 29710516

Investigation of Ginkgo biloba extract (EGb 761) promotes neurovascular restoration and axonal remodeling after embolic stroke in rat using magnetic resonance imaging and histopathological analysis.

Man-Zhong Li1, Yi Zhang2, Hai-Yan Zou1, Jun-Yao Ouyang1, Yu Zhan1, Le Yang1, Brian Chi-Yan Cheng3, Lei Wang1, Qiu-Xia Zhang1, Jian-Feng Lei4, Yuan-Yuan Zhao4, Hui Zhao5.   

Abstract

EGb 761 is a standardized natural extract from Ginkgo biloba leaf that has shown neuroprotective effects after ischemic stroke. This study aimed to use magnetic resonance imaging (MRI) to noninvasively evaluate whether EGb 761 promotes neurovascular restoration and axonal remodeling in a rat model of focal cerebral ischemia. Male Sprague-Dawley rats were subjected to permanent right middle cerebral artery occlusion (MCAO) and treated with EGb 761 (60 mg/kg) or saline intragastrically once daily for 15 days starting 6 h after MCAO. Functional recovery was analyzed using beam walking test. Multi-parametric MRI was applied to examine the alterations of gray-white structures, intracranial vessels, cerebral perfusion and axonal integrity, and followed with histological studies. Furthermore, the protein expression of axonal remodeling related signaling pathways including protein kinase B (AKT)/ glycogen synthase kinase-3β (GSK-3β)/ collapsin response mediator protein 2 (CRMP2) and NogoA/NgR were detected by Western blotting analysis. Multi-parametric MRI demonstrated that EGb 761 significantly reduced infarct volume, alleviated gray and white matter damage, and enhanced collateral circulation, cerebral perfusion and axonal remodeling. Histological examinations supported the MRI results. EGb 761 treatment facilitated behavioral recovery and amplified endogenous neurogenesis. Notably, treatment with EGb 761 significantly increased the levels of p-AKT, p-GSK-3β and decreased the expression of p-CRMP2. In addition, EGb 761 treatment up-regulated the expression of growth associated protein 43 (GAP-43) and suppressed the activation of axonal growth inhibitory molecules NogoA and NgR. These findings indicated that EGb 761 enhanced neurovascular restoration, amplified endogenous neurogenesis and promoted axonal regeneration, which in concert may contribute to gray-white matter reorganization and functional outcome after stroke.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Axonal remodeling; EGb 761; Ischemic stroke; Magnetic resonance imaging; Neurovascular restoration

Mesh:

Substances:

Year:  2018        PMID: 29710516     DOI: 10.1016/j.biopha.2018.04.125

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Intermittent hypoxia promotes the recovery of motor function in rats with cerebral ischemia by regulating mitochondrial function.

Authors:  Yue Su; Changkai Ke; Chen Li; Chuan Huang; Chunxiao Wan
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

2.  Long-term administration of salvianolic acid A promotes endogenous neurogenesis in ischemic stroke rats through activating Wnt3a/GSK3β/β-catenin signaling pathway.

Authors:  Sen Zhang; De-Wen Kong; Guo-Dong Ma; Cheng-di Liu; Yu-Jiao Yang; Shan Liu; Nan Jiang; Zi-Rong Pan; Wen Zhang; Ling-Lei Kong; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

3.  MRI Evaluation of Axonal Remodeling After Combination Treatment With Xiaoshuan Enteric-Coated Capsule and Enriched Environment in Rats After Ischemic Stroke.

Authors:  Man-Zhong Li; Yu Zhan; Le Yang; Xue-Feng Feng; Hai-Yan Zou; Jian-Feng Lei; Ting Zhao; Lei Wang; Hui Zhao
Journal:  Front Physiol       Date:  2019-12-19       Impact factor: 4.566

Review 4.  Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke.

Authors:  Ting Zhu; Lei Wang; Yicheng Feng; Guibo Sun; Xiaobo Sun
Journal:  Oxid Med Cell Longev       Date:  2021-03-13       Impact factor: 6.543

5.  Ginkgo biloba leaf extract (EGb-761) elicits neuroprotection against cerebral ischemia/reperfusion injury by enhancement of autophagy flux in neurons in the penumbra.

Authors:  Deng Yihao; Guo Tao; Wu Zhiyuan; Zhao Xiaoming; Dong Lingling; He Hongyun
Journal:  Iran J Basic Med Sci       Date:  2021-08       Impact factor: 2.699

6.  The Impact of Ischemic Stroke on Gray and White Matter Injury Correlated With Motor and Cognitive Impairments in Permanent MCAO Rats: A Multimodal MRI-Based Study.

Authors:  Le Yang; Manzhong Li; Yu Zhan; Xuefeng Feng; Yun Lu; Mingcong Li; Yuming Zhuang; Jianfeng Lei; Hui Zhao
Journal:  Front Neurol       Date:  2022-03-02       Impact factor: 4.003

7.  Magnetic Resonance Imaging Investigation of Neuroplasticity After Ischemic Stroke in Tetramethylpyrazine-Treated Rats.

Authors:  Xue-Feng Feng; Jian-Feng Lei; Man-Zhong Li; Yu Zhan; Le Yang; Yun Lu; Ming-Cong Li; Yu-Ming Zhuang; Lei Wang; Hui Zhao
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

8.  Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease.

Authors:  Yu-Chen Yan; Zhi-Heng Xu; Jian Wang; Wen-Bo Yu
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

9.  Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke.

Authors:  Jian Zhang; Shengpan Chen; Weilong Shi; Manzhong Li; Yu Zhan; Le Yang; Haiyan Zou; Jianfeng Lei; Xinlou Chai; Kuo Gao; Junjie Liu; Wei Wang; Yong Wang; Hui Zhao
Journal:  Cell Transplant       Date:  2018-10-04       Impact factor: 4.064

10.  Effect of Neurorepair for Motor Functional Recovery Enhanced by Total Saponins From Trillium tschonoskii Maxim. Treatment in a Rat Model of Focal Ischemia.

Authors:  Le Yang; Jian-Feng Lei; Jun-Yao Ouyang; Man-Zhong Li; Yu Zhan; Xue-Feng Feng; Yun Lu; Ming-Cong Li; Lei Wang; Hai-Yan Zou; Hui Zhao
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.